Wilson Sonsini Advises Beren Therapeutics P.B.C. on $300 Million Financing, Including Equity and Debt and Royalty Facilities
Life Sciences
Our Industry Coverage
With one of the largest life sciences practices in the U.S., Wilson Sonsini’s industry legacy dates to the formative years of biotech and medical device. Working closely with scientists and entrepreneurs who grew their companies into thriving businesses, we have worked alongside to support their endeavors from whiteboard to clinical trial and beyond.
Industry Highlights
Celebrating our founders’ successes
2024
USANA Health Sciences on Acquisition of Hiya Health
Nutritional Supplements, Functional Foods and Personal Care Products2024
LaNova Medicines on Exclusive Global License with Merck
Biotechnology2024
Borealis Biosciences Announces $150 Million Series A and Strategic Collaboration Funding
RNA Medicines2023
DTx Pharma Announces Acquisition by Novartis
Biotechnology2023
Aspect Biosystems Announces $2.7 Billion Collaboration with Novo Nordisk
Biotechnology2023
Chroma Medicine Lands $135 Million Series B Financing
Genomics2022
Arcellx, Inc. Raises $124 Million IPO
Biotechnology2021
Ventyx Biosciences Closes IPO at $175 Million
Biotechnology, Pharmaceuticals2021
Tenaya Therapeutics Completes IPO Worth $207 Million
Biotechnology2021
Kinnate Biopharma Raises $276 Million IPO
Drug Discovery, Pharmaceuticals2020
Seer IPO Raises $175 Million in Nasdaq Debut
Decision / Risk Analysis2020
PMV Pharmaceuticals Joins Nasdaq with $211 Million IPO
Drug Discovery2020
Athira Pharma Closes $204 Million IPO
Drug Discovery2020
ALX Oncology Prices IPO at $161 Million
Immuno-Oncology2020
Applied Molecular Transport Closes IPO at $154 Million
Pharmaceuticals2020
Oric Pharmaceuticals IPO Raises $120 Million
Drug Discovery2019
Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination
Generics and Specialty PharmaceuticalsAttorneys
focused
on this
industry
recent news
we want to share
with you
Wilson Sonsini Advises Isomorphic Labs on $2.1 Billion Series B Investment Round
Wilson Sonsini Advises Isomorphic Labs on $2.1 Billion Series B Investment Round
Client Highlights06/03/26
Wilson Sonsini Advises BioOrbit on $13.2 Million Seed Round
Wilson Sonsini Advises BioOrbit on $13.2 Million Seed Round
Client Highlights05/06/26
Wilson Sonsini Represents Investors in Windward Bio’s $165 Million Crossover Financing
Wilson Sonsini Represents Investors in Windward Bio’s $165 Million Crossover Financing
Client Highlights05/05/26